Centiva Capital’s PRA Health Sciences, Inc. PRAH Stock Holding History

Centiva Capital’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,423	Closed	-$400K	–	1800
2021 Q2	$400K	Sell	2,423 -8,577	-78%	-$1.43M	0.01%	916
2021 Q1	$1.69M	Buy	+11,000	New	+$1.49M	0.06%	220
2020 Q1	–	Sell	-5,079	Closed	-$565K	–	995
2019 Q4	$565K	Buy	+5,079	New	+$522K	0.03%	403

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Centiva Capital's PRAH Position: Q3 2021 in Review

Centiva Capital sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 2,423 shares — an estimated $400K sold.

Centiva Capital first reported a position in PRAH in Q4 2019 and held it in 3 quarters. The position peaked at $1.69M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Centiva Capital reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Centiva Capital sold 2,423 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $400K.
Centiva Capital first reported a position in PRA Health Sciences, Inc. in Q4 2019 and held it in 3 quarters.
Centiva Capital's PRA Health Sciences, Inc. position peaked at $1.69M in Q1 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Centiva Capital's 13F filing for Q3 2021, filed 15 Nov 2021.